Ardsley Advisory Partners LP Coherus Bio Sciences, Inc. Transaction History

Ardsley Advisory Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$16.3 - $23.37 $407,500 - $584,250	-25,000 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$13.1 - $22.1 $327,500 - $552,500	-25,000 Reduced 50.0%	25,000 $553,000
Q1 2019 May 15, 2019	BUY	$8.38 - $15.5 $293,300 - $542,500	35,000 Added 233.33%	50,000 $682,000
Q2 2018 Aug 14, 2018	SELL	$10.25 - $17.45 $153,750 - $261,750	-15,000 Reduced 50.0%	15,000 $210,000
Q1 2018 May 15, 2018	BUY	$9.1 - $13.7 $273,000 - $411,000	30,000 New	30,000 $332,000

133

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.